| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.20B | 28.73B | 31.82B | 31.04B | 27.36B | 21.82B |
| Gross Profit | 3.73B | 3.85B | 3.67B | 4.17B | 2.14B | 3.45B |
| EBITDA | 1.75B | 1.86B | 1.77B | 2.20B | 243.67M | 1.83B |
| Net Income | 506.66M | 572.17M | 467.90M | 1.01B | -967.69M | 729.41M |
Balance Sheet | ||||||
| Total Assets | 26.34B | 26.69B | 28.76B | 27.96B | 26.54B | 26.62B |
| Cash, Cash Equivalents and Short-Term Investments | 2.08B | 2.24B | 2.77B | 2.25B | 2.71B | 6.19B |
| Total Debt | 2.58B | 2.71B | 3.77B | 3.81B | 3.76B | 2.71B |
| Total Liabilities | 8.65B | 8.90B | 11.79B | 11.54B | 11.17B | 10.44B |
| Stockholders Equity | 17.69B | 17.79B | 16.97B | 16.42B | 15.37B | 16.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 611.88M | 657.82M | -469.24M | -4.52B | 87.68M |
| Operating Cash Flow | 0.00 | 1.62B | 2.03B | 898.68M | -2.47B | 1.73B |
| Investing Cash Flow | 0.00 | -1.03B | -1.13B | -1.28B | -2.02B | -1.49B |
| Financing Cash Flow | 0.00 | -1.12B | -380.25M | -74.78M | 1.00B | 2.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥389.88B | 11.54 | ― | 3.26% | -7.77% | 58.84% | |
72 Outperform | ¥57.85B | 5.95 | ― | 6.31% | -8.44% | 9.50% | |
70 Outperform | ¥115.38B | 12.02 | ― | 3.70% | -3.06% | 1.15% | |
64 Neutral | ¥4.99B | 138.69 | ― | 3.17% | -20.10% | -14.13% | |
64 Neutral | ¥34.32B | 12.12 | ― | 5.02% | -13.64% | -45.74% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥59.39B | 5.98 | ― | 6.27% | -7.45% | -9.12% |